Skip to content

Comparison of the effect of MIND diet and propolis supplement on metabolic syndrome and cognitive function

Comparison of the effects of MIND diet and propolis supplementation on metabolic syndrome indices and cognitive function and its areas in people with metabolic syndrome. Randomized controlled clinical trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230105057054N1
Enrollment
84
Registered
2023-03-28
Start date
2023-05-31
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: metabolic syndrome. Condition 2: cognitive function. Metabolic syndrome Other symptoms and signs involving cognitive functions and awareness

Interventions

Intervention 1: First intervention group: MIND diet and placebo. The counseling plan for the intervention diet group will include instructions on what foods to include in the diet, the paths to provid

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Participants must provide informed consent prior to engaging in the study Adults (18-60 years old) have metabolic syndrome

Exclusion criteria

Exclusion criteria: Suffering from thyroid diseases, anemia, diabetes, neurological and psychiatric illnesses containing depression, Parkinson's disease, Alzheimer's disease, mental disorders and, a history of severe medical treatment. Have a stroke or transient ischemic attack in the last 3 months. Have a history of brain damage, liver and kidney disease, hepatitis C or HIV. have been diagnosed with cancer in the last five years. Obese people with a BMI higher than 40

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: Before and after study. Method of measurement: blood sample.;Triglyceride. Timepoint: Before and after study. Method of measurement: blood sample.;High density lipoprotein cholesterol. Timepoint: Before and after study. Method of measurement: blood sample.;Blood pressure. Timepoint: Before and after study. Method of measurement: sphygmomanometer.;Cognitive function. Timepoint: Before and after study. Method of measurement: Neuropsychiatry Unit Cognitive Assessment.;Waist. Timepoint: Before and after study. Method of measurement: inflexible meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Zamzam Paknahad

Esfahan University of Medical Sciences

paknahad@hlth.mui.ac.ir+98 31 3792 3166

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Apr 29, 2026